Controlling High Blood Pressure: An Evidence-Based Blueprint for Change.


Journal

American journal of medical quality : the official journal of the American College of Medical Quality
ISSN: 1555-824X
Titre abrégé: Am J Med Qual
Pays: Netherlands
ID NLM: 9300756

Informations de publication

Date de publication:
Historique:
pubmed: 27 5 2021
medline: 12 1 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

Recently published national data demonstrate inadequate and worsening control of high blood pressure (HBP) in the United States, outcomes that likely have been made even worse by the coronavirus disease 2019 (COVID-19) pandemic. This major public health crisis exposes shortcomings of the US health care delivery system and creates an urgent opportunity to reduce mortality, major cardiovascular events, and costs for 115 million Americans. Ending this crisis will require a more coherent and systemic change to traditional patterns of care. The authors present an evidence-based Blueprint for Change for comprehensive health delivery system redesign based on current national clinical practice guidelines and quality measures. This innovative model includes a systems-based approach to ensuring proper BP measurement, assessment of cardiovascular risk, effective patient-centered team-based care, addressing social determinants of health, and shared decision-making. The authors also propose building on current national quality improvement initiatives designed to better control HBP.

Identifiants

pubmed: 34038915
doi: 10.1097/01.JMQ.0000749856.90491.43
pii: 00008488-202201000-00004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

22-31

Informations de copyright

Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.

Références

Muntner P, Carey RM, Gidding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137:109–118.
Curfman G, Bauchner H, Greenland P. Treatment and control of hypertension in 2020: the need for substantial improvement. JAMA. 2020;324:1166–1167.
Muntner P, Hardy ST, Fine LJ, et al. Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324:1190–1200.
Colantonio LD, Booth JN 3rd, Bress AP, et al. 2017 ACC/AHA blood pressure treatment guideline recommendations and cardiovascular risk. J Am Coll Cardiol. 2018;72:1187–1197.
Virani SS, Alonso A, Benjamin EJ, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596.
Kirkland EB, Heincelman M, Bishu KG, et al. Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003-2014. J Am Heart Assoc. 2018;7:e008731.
Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248.
Casey DE Jr, Thomas RJ, Bhalla V, et al. 2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes. 2019;12:e000057.
Casey D. The ACMQ 2019 quality institute: blueprint for change. Am J Med Qual. 2019;34:418–419.
Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646.
Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;67:1572–1574.
Muntner P, Shimbo D, Carey RM, et al; on behalf of the American Heart Association Council on Hypertension; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertens. 2019;73:e35–e66.
Drawz PE, Agarwal A, Dwyer JP, et al. Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice. JAMA Intern Med. 2020;180:1655–1663.
Piper MA, Evans CV, Burda BU, et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192–204.
Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2:775–781.
Jones DW, Appel LJ, Sheps SG, et al. Measuring blood pressure accurately: new and persistent challenges. JAMA. 2003;289:1027–1030.
Shimbo D, Artinian NT, Basile JN, et al; American Heart Association and the American Medical Association. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Circulation. 2020;142:e42–e63.
Kitt J, Fox R, Tucker KL. Digital health: new approaches in hypertension management. J Cardiol and Cardiovasc Sciences. 2020;4:18–23.
Havranek EP, Mujahid MS, Barr DA, et al; American Heart Association Council on Quality of Care and Outcomes Research, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, Council on Lifestyle and Cardiometabolic Health, and Stroke Council. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–898.
Carey RM, Muntner P, Bosworth HB, et al. Prevention and control of hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72:1278–1293.
Davidson KW, Kemper AR, Doubeni CA, et al. Developing primary care-based recommendations for social determinants of health: methods of the U.S. Preventive Services Task Force. Ann Intern Med. 2020;173:461–467.
Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361–1367.
Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891.
Langford AT, Williams SK, Applegate M, et al. Partnerships to improve shared decision making for patients with hypertension - health equity implications. Ethn Dis. 2019;29(suppl 1):97–102.
Proia KK, Thota AB, Njie GJ, et al; Community Preventive Services Task Force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99.
Clark CE, Smith LF, Taylor RS, et al. Nurse led interventions to improve control of blood pressure in people with hypertension: systematic review and meta-analysis. BMJ. 2010;341:c3995.
Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.
Victor RG, Lynch K, Li N, et al. A cluster-randomized trial of blood-pressure reduction in black barbershops. N Engl J Med. 2018;378:1291–1301.
O’Brien MJ, Squires AP, Bixby RA, et al. Role development of community health workers: an examination of selection and training processes in the intervention literature. Am J Prev Med. 2009;37(6 suppl 1):S262–S269.
Schoenthaler AM, Lancaster KJ, Chaplin W, et al. Cluster randomized clinical trial of FAITH (Faith-Based Approaches in the Treatment of Hypertension) in Blacks. Circ Cardiovasc Qual Outcomes. 2018;11:e004691.

Auteurs

Donald E Casey (DE)

Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA Department of Medicine, Rush Medical College, Rush University, Chicago, IL University of Minnesota, Institute for Healthcare Informatics, Minneapolis, MN Booz Allen Hamilton Inc, Bethesda, MD University of Illinois at Chicago, School of Public Health, Chicago, IL Department of Medicine, University of Virginia Health System, Charlottesville, VA Johns Hopkins University, School of Nursing, Baltimore, MD Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Rutgers University School of Nursing, New Brunswick, NJ American Heart Association, Dallas, TX American Medical Association, Chicago, IL Division of Nephrology and Hypertension, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH